Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
出版年份 2022 全文链接
标题
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
作者
关键词
-
出版物
Diabetes Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-02-15
DOI
10.1007/s13300-022-01217-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action
- (2021) Francesco Maranta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Randomized Clinical Trial or Real-World Evidence: How Historical Events, Public Demand, and the Resulting Laws and Regulations Shaped the Body of Medical Evidence
- (2021) John I. Mackowiak et al. JOURNAL OF ORTHOPAEDIC TRAUMA
- Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel
- (2021) Wael Al Mahmeed et al. Frontiers in Cardiovascular Medicine
- Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management
- (2020) Anca Pantea Stoian et al. Metabolic Syndrome and Related Disorders
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
- (2020) Dragana Nikolic et al. Diabetes Therapy
- Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: Physician survey and good clinical practice recommendations from an international expert panel
- (2020) Maciej Banach et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study
- (2019) Angelo Maria Patti et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial
- (2019) Christian Anholm et al. ATHEROSCLEROSIS
- GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
- (2018) Manfredi Rizzo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study
- (2018) Niina Matikainen et al. DIABETES OBESITY & METABOLISM
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- Excess Mortality among Persons with Type 2 Diabetes
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 DiabeticsSignificance
- (2015) Arman Qamar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
- (2014) Maria-Agata Miselli et al. Cardiovascular Diabetology
- Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
- (2014) Nicola Abate et al. CURRENT PHARMACEUTICAL DESIGN
- Prevalence of dyslipidemia and associated risk factors in Turkish adults
- (2014) Fahri Bayram et al. Journal of Clinical Lipidology
- A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis
- (2014) Yuko Tashiro et al. PEPTIDES
- The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse model
- (2013) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
- (2013) E. R. Seaquist et al. DIABETES CARE
- Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
- (2013) K. Hermansen et al. DIABETES OBESITY & METABOLISM
- Predictors of Insulin Resistance in Patients With Obesity
- (2012) Mariusz Stępień et al. ANGIOLOGY
- Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study
- (2010) Egle Corrado et al. CORONARY ARTERY DISEASE
- Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
- (2010) B. P. Cummings et al. DIABETES
- Ethnic differences in serum lipoproteins and their determinants in South African women
- (2010) Julia H. Goedecke et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis
- (2009) Manfredi Rizzo et al. ATHEROSCLEROSIS
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
- (2008) Kaspar Berneis et al. EXPERT OPINION ON PHARMACOTHERAPY
- Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
- (2008) K. Berneis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
- (2007) Manfredi Rizzo et al. ATHEROSCLEROSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now